Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer (2017)
Attributed to:
The central importance of CXCL8 signaling to inflammatory-based tumour initiation and invasive prostate carcinoma.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx361.028
Publication URI: http://dx.doi.org/10.1093/annonc/mdx361.028
Type: Journal Article/Review
Parent Publication: Annals of Oncology